Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,612 | 2,108 | 1,252 | 1,389 | 1,084 |
| Income taxes - deferred | -4,686 | -77 | -134 | -168 | 290 |
| Accounts receivable | -799 | -100 | -1,626 | 603 | -2,136 |
| Other Working Capital | 706 | 4,403 | -659 | 1,476 | -2,798 |
| Other Operating Activity | 4,356 | 1,338 | 3,546 | 2,307 | 5,818 |
| Operating Cash Flow | $1,189 | $7,673 | $2,379 | $5,607 | $2,259 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -518 | -1,003 | -744 | -342 | -358 |
| Purchase Of Investment | 0 | 0 | 2 | 0 | -30 |
| Investing Cash Flow | $-518 | $-1,004 | $-742 | $-342 | $-388 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -102 | -83 | N/A | N/A |
| Dividend Paid | -1,219 | -2,102 | -3,511 | -5,164 | 0 |
| Other Financing Activity | -148 | 7 | 15 | -49 | -102 |
| Financing Cash Flow | $-1,367 | $-2,196 | $-3,579 | $-5,212 | $-102 |
| Exchange Rate Effect | 1 | 5 | 1 | 7 | -6 |
| Beginning Cash Position | 14,810 | 9,831 | 12,483 | 12,386 | 10,622 |
| End Cash Position | 14,114 | 14,472 | 9,831 | 12,483 | 12,386 |
| Net Cash Flow | $-697 | $4,473 | $-1,942 | $53 | $1,770 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,189 | 7,673 | 2,379 | 5,607 | 2,259 |
| Capital Expenditure | -518 | -1,001 | -728 | -415 | -513 |
| Free Cash Flow | 671 | 6,672 | 1,651 | 5,192 | 1,746 |